Cleared Traditional

K090809 - MPS ACACIA POWER INJECTABLE INFUSION SET

K090809 is an FDA 510(k) clearance for MPS ACACIA POWER INJECTABLE INFUSION SET, manufactured by Mps Acacia. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 34-day FDA review.

K090809 · Mps Acacia · General Hospital
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Apr 2009
Decision
34d
Days
Class 2
Risk

K090809 is an FDA 510(k) clearance for the MPS ACACIA POWER INJECTABLE INFUSION SET. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Mps Acacia (Brea, US). The FDA issued a Cleared decision on April 28, 2009 after a review of 34 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K090809

510(k) Number K090809 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 25, 2009
Decision Date April 28, 2009
Days to Decision 34 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
95d faster than avg
Panel avg: 129d · This submission: 34d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Consultant

Regulatory Technology Services, LLC
MARK JOB

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - FPA Set, Administration, Intravascular

All 951
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K090809.
BAIXIN INTRAVASCULAR ADMINISTRATION SET
K083687 · Anhui Kangda Medical Products Co., Ltd. · Jun 2009
DISPOSABLE INFUSION SET
K090012 · Shan Dong Wei Gao Group Medical Polymer Products · Jun 2009
A6 LUER ACCESS DEVICE
K083723 · B.Braun Medical, Inc. · Jun 2009
INTRAVENOUS POWER INJECTOR EXTENSION SET
K090134 · C.R. Bard, Inc. · Apr 2009
ANTIMICROBIAL CLAVE, MODELS AG CLAVE, AG MICROCLAVE
K090189 · Icu Medical, Inc. · Apr 2009
SPINNING SPIROS, MODEL CH-2000
K082806 · Icu Medical, Inc. · Apr 2009

FDA 510(k) Resources - General Hospital

Additional regulatory intelligence related to this FDA 510(k) submission, including predicate strategy, review pathways and device classification guidance.